Clinical Trial Update: A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of oral ganaxolone in women with postpartum depression has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Major Depressive Disorder
• Postpartum Depression

Drugs mentioned

• ganaxolone (ganaxolone)

Snippet

Sponsor: Marinus Pharmaceuticals | Conditions: Depressive Disorder, Depression | Phase 2 | Status: COMPLETED | Results posted: 2023-01-30